Adaptive Biotechnologies Corporation
ADPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,280 | $1,772 | $1,109 | $883 |
| - Cash | $55 | $43 | $51 | $48 |
| + Debt | $214 | $84 | $87 | $89 |
| Enterprise Value | $2,439 | $1,813 | $1,145 | $924 |
| Revenue | $94 | $59 | $52 | $47 |
| % Growth | 59.6% | 12.3% | 10.5% | – |
| Gross Profit | $76 | $41 | $35 | $29 |
| % Margin | 80.7% | 69.4% | 67.6% | 62% |
| EBITDA | $17 | -$18 | -$30 | -$26 |
| % Margin | 18% | -30.8% | -56.4% | -55.5% |
| Net Income | $10 | -$26 | -$30 | -$34 |
| % Margin | 10.2% | -43.5% | -56.9% | -71% |
| EPS Diluted | 0.06 | -0.17 | -0.2 | -0.23 |
| % Growth | 135.3% | 15% | 13% | – |
| Operating Cash Flow | -$7 | -$12 | -$28 | -$12 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$8 | -$13 | -$30 | -$13 |